DK1115743T3 - Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse - Google Patents

Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse

Info

Publication number
DK1115743T3
DK1115743T3 DK99949923T DK99949923T DK1115743T3 DK 1115743 T3 DK1115743 T3 DK 1115743T3 DK 99949923 T DK99949923 T DK 99949923T DK 99949923 T DK99949923 T DK 99949923T DK 1115743 T3 DK1115743 T3 DK 1115743T3
Authority
DK
Denmark
Prior art keywords
molecular weight
weight markers
copolymer
copolymers
glatiramer acetate
Prior art date
Application number
DK99949923T
Other languages
Danish (da)
English (en)
Inventor
Alexander Gad
Dora Lis
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22285926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1115743(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK1115743T3 publication Critical patent/DK1115743T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
DK99949923T 1998-09-25 1999-09-24 Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse DK1115743T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10169398P 1998-09-25 1998-09-25
PCT/US1999/022402 WO2000018794A1 (en) 1998-09-25 1999-09-24 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Publications (1)

Publication Number Publication Date
DK1115743T3 true DK1115743T3 (da) 2009-07-27

Family

ID=22285926

Family Applications (3)

Application Number Title Priority Date Filing Date
DK09004306.8T DK2090583T3 (da) 1998-09-25 1999-09-24 Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse
DK10171553.0T DK2239269T3 (da) 1998-09-25 1999-09-24 Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører
DK99949923T DK1115743T3 (da) 1998-09-25 1999-09-24 Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK09004306.8T DK2090583T3 (da) 1998-09-25 1999-09-24 Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse
DK10171553.0T DK2239269T3 (da) 1998-09-25 1999-09-24 Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører

Country Status (18)

Country Link
EP (3) EP1115743B1 (de)
JP (2) JP4629229B2 (de)
AT (2) ATE431359T1 (de)
AU (1) AU757413B2 (de)
CA (2) CA2343929C (de)
CY (3) CY1110490T1 (de)
DE (2) DE09004306T1 (de)
DK (3) DK2090583T3 (de)
ES (3) ES2327301T3 (de)
HK (3) HK1040521A1 (de)
HU (3) HU229720B1 (de)
IL (4) IL142116A0 (de)
NO (2) NO329877B1 (de)
NZ (1) NZ511020A (de)
PT (3) PT2239269E (de)
SI (1) SI1115743T1 (de)
WO (1) WO2000018794A1 (de)
ZA (1) ZA200102269B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2337688C (en) 1998-07-23 2016-04-05 Yeda Research And Development Co., Ltd. Treatment of autoimmune conditions with copolymer 1 and related copolymers
ES2527760T3 (es) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US7022663B2 (en) 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
WO2001097785A2 (en) * 2000-06-20 2001-12-27 Caprion Pharmaceuticals Inc. Basic copolymers for the treatment of prion-related-disease
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
AU2002362445B2 (en) * 2001-10-03 2006-09-21 President And Fellows Of Harvard College Copolymers for suppression of autoimmune diseases, and methods of use
ES2349033T3 (es) 2001-12-04 2010-12-22 Teva Pharmaceutical Industries, Ltd. Procedimientos para la medida de la actividad del acetato de glatiramer.
NZ569331A (en) 2003-01-21 2010-08-27 Yeda Res & Dev COP 1 for treatment of inflammatory bowel diseases
CN102120031B (zh) 2003-08-07 2012-12-05 希尔洛有限公司 用于加速伤口愈合的药物组合物和方法
BRPI0508382A (pt) * 2004-03-01 2007-07-31 Peptimmune Inc métodos e composições para tratamento de doenças auto-imunes
US7655221B2 (en) 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
SI1797109T1 (sl) 2004-09-09 2016-07-29 Yeda Research And Development Co., Ltd. Zmesi polipeptidov, sestavki, ki jih vsebujejo, in postopki za njihovo pripravo ter njihove uporabe
US7858337B2 (en) 2007-03-08 2010-12-28 Novartis Ag Process for the manufacture of a composite material
CA2760802C (en) 2009-08-20 2016-01-12 Ety Klinger Low frequency glatiramer acetate therapy
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
US8759302B2 (en) 2010-03-16 2014-06-24 Teva Pharmaceutical Industries, Ltd. Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
NZ703122A (en) 2010-10-11 2016-06-24 Teva Pharma Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
WO2012123959A2 (en) 2011-02-14 2012-09-20 Usv Limited Copolymer-1, process for preparation and analytical methods thereof
WO2013055683A1 (en) 2011-10-10 2013-04-18 Teva Pharmaceutical Industries Ltd. Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate
US9617596B2 (en) 2012-10-10 2017-04-11 Teva Pharmaceutical Industries, Ltd. Biomarkers predictive for clinical response for glatiramer acetate
CN104098655B (zh) * 2013-04-09 2018-01-30 深圳翰宇药业股份有限公司 用于合成醋酸格拉替雷的质谱内标的多肽
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
CN105218646B (zh) * 2014-06-24 2018-09-21 深圳翰宇药业股份有限公司 一种用于检测醋酸格拉替雷样本的uplc方法
US9155775B1 (en) 2015-01-28 2015-10-13 Teva Pharmaceutical Industries, Ltd. Process for manufacturing glatiramer acetate product
EP3603764B1 (de) * 2015-04-28 2022-03-30 Hybio Pharmaceutical Co., Ltd. Hochleistungsflüssigchromatografieverfahren
EP3147667B1 (de) * 2015-09-24 2019-06-12 CHEMI S.p.A. Analyse der molekulargewichtsverteilung von komplexen polypeptidmischungen
CA3050086A1 (en) 2017-03-26 2018-10-04 Mapi Pharma Ltd. Glatiramer depot systems for treating progressive forms of multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2009996A1 (en) * 1989-02-17 1990-08-17 Kathleen S. Cook Process for making genes encoding random polymers of amino acids
US5800808A (en) 1994-05-24 1998-09-01 Veda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers

Also Published As

Publication number Publication date
IL209189A0 (en) 2011-01-31
CY1112197T1 (el) 2015-12-09
HK1040521A1 (en) 2002-06-14
EP2090583B1 (de) 2011-07-13
HU229289B1 (en) 2013-10-28
AU6269599A (en) 2000-04-17
DK2090583T3 (da) 2011-09-12
ATE431359T1 (de) 2009-05-15
EP2090583A1 (de) 2009-08-19
CA2343929A1 (en) 2000-04-06
ZA200102269B (en) 2002-03-19
IL209189A (en) 2017-11-30
HU229719B1 (en) 2014-05-28
IL209190A (en) 2017-11-30
AU757413B2 (en) 2003-02-20
ES2408706T3 (es) 2013-06-21
IL142116A0 (en) 2002-03-10
JP4629229B2 (ja) 2011-02-09
ATE516297T1 (de) 2011-07-15
EP2239269B1 (de) 2013-01-16
JP4903886B2 (ja) 2012-03-28
HU229720B1 (en) 2014-05-28
DE09004306T1 (de) 2010-12-09
JP2002525378A (ja) 2002-08-13
CA2343929C (en) 2013-01-29
NO20011441D0 (no) 2001-03-21
HK1149279A1 (en) 2011-09-30
EP1115743A4 (de) 2005-04-27
PT2090583E (pt) 2011-09-14
HUP0103889A3 (en) 2004-03-01
NO329877B1 (no) 2011-01-17
DK2239269T3 (da) 2013-04-29
HUP0103889A2 (hu) 2002-03-28
WO2000018794A1 (en) 2000-04-06
CA2794705C (en) 2017-07-18
ES2327301T3 (es) 2009-10-27
NZ511020A (en) 2003-06-30
NO20100442L (no) 2001-05-25
HK1133021A1 (en) 2010-03-12
NO20011441L (no) 2001-05-25
PT1115743E (pt) 2009-07-07
SI1115743T1 (sl) 2010-01-29
EP2239269A1 (de) 2010-10-13
CY1110490T1 (el) 2015-04-29
CY1113932T1 (el) 2016-07-27
NO336685B1 (no) 2015-10-19
PT2239269E (pt) 2013-04-09
EP1115743B1 (de) 2009-05-13
CA2794705A1 (en) 2000-04-06
IL142116A (en) 2010-12-30
EP1115743A1 (de) 2001-07-18
DE69940888D1 (de) 2009-06-25
JP2010271325A (ja) 2010-12-02
IL209190A0 (en) 2011-01-31
ES2369642T3 (es) 2011-12-02

Similar Documents

Publication Publication Date Title
DK1115743T3 (da) Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse
DE68917183D1 (de) Elastisches Lager.
TR200200938T2 (tr) CCR5 modülatörleri olarak piperidinler
ATE253352T1 (de) Verwendung einer zusammensetzung enthaltend polyether block copolymere
DK641589D0 (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
NO862545D0 (no) Vannbasert polymermateriale og fremgangsmaate til fremstilling, samt anvendelse derav.
NO895265L (no) Fremgangsmaate for fremstilling av kationiske akrylamidpolymerer, kationiske akrylamidpolymerer og anvendelse av disse.
DE59201610D1 (de) Aktives, elastisches Lager.
DE58903654D1 (de) Elastisches lager.
NO862975D0 (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO862976L (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO874786D0 (no) Optisk aktive gyrasehemmere, deres fremstilling og anvendelse som antibiotika.
IT8521309A0 (it) Dispositivo e procedimento per sterilizzare articoli, in particolare strumenti chirurgici, strumenti odontotecnici e simili.
DK565088D0 (da) Polymetalliske, molekylaere systemer med ferromagnetiske egenskaber, fremgangsmaade til deres fremstilling og anvendelse deraf, isaer som ferromagnetiske forbindelser
DK564689D0 (da) Bacillus thuringiensisstammer og fremgangsmaade til fremstilling deraf, samt deres anvendelse som insekticider
NO884246D0 (no) Universalledd, eksempelvis til bruk som hofteledd.
IT8941774A0 (it) Base per sedie, poltroncine o simili
NO894682D0 (no) Liggeunderlag til bruk i sykeseng for pasienter med liggesaar, brannsaar eller lignende.